Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Accelerating Implementation of Long-Acting Injectables
The ALAI UP Project will support the implementation and delivery of LAI ARV at 10 demonstration sites in EHE jurisdictions in New York City (NYC) and the Southeast (SE) region of the US providing care to underserved populations and communities of color.RWHAP Technical Assistance Provider updated on 03/06/2024
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024 -
Rapid ART Program Initiative for New Diagnoses
Rapid ART Program Initiative for New Diagnoses (RAPID) was designed to connect people with a new HIV diagnosis to ART within five days of diagnosis and within one day of their initial care visit. Linkage navigators counseled people on HIV care, identified an available clinician capable of immediately prescribing ART, scheduled the clinical appointment, and connected people to additional support services. RAPID led to a reduction in median time between initial diagnosis and both ART initiation and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
-
National HIV PrEP Curriculum
Online learning portal for clinicians on pre-exposure prophylaxis (PrEP) for prevention of HIV.Resource updated 03/13/2024
-
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
-
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
-
National Clinician Consultation Center
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
-
HIV/AIDS Guidelines
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
-
Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
-
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
HRSA HAB Notice of Funding Opportunity (NOFO) Announcements
Pre-application webinars for Notice of Funding Opportunity (NOFO) announcements from HRSA's HIV/AIDS Bureau for the Ryan White HIV/AIDS Program (RWHAP).
Resource updated 03/07/2024
-
PrEP Policies and Programs Help End the HIV Epidemic
Summary of pre-exposure prophylaxis (PrEP) provisions under HRSA and the Ryan White HIV/AIDS Program and PrEP resources on coverage and costs and providers with PrEP expertise.
Blog updated 11/14/2023
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
National HIV Curriculum
Online clinician training platform with evidence-based core competency training on HIV prevention, screening, diagnosis, care, and key populations.
Resource updated 09/19/2023
-
Toolkit Features State Strategies to Improve the Health of People with HIV
HHS has supported development of a toolkit on state Medicaid and health department coordination to improve HIV care delivery.
Blog updated 12/28/2022